| Yu, Min |
NCT05334823: A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents |
|
|
| Recruiting | 2 | 100 | RoW | pCAR-19B cells | Chongqing Precision Biotech Co., Ltd | Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia | 12/24 | 07/25 | | |
SCS-Lung01, NCT06217757: Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC |
|
|
| Recruiting | 1/2 | 45 | RoW | Low-dose radiotherapy, LDRT, Etoposide, One of the standard chemotherapy regimens, Cisplatin, Sugemalimab, Programmed Death Ligand-1 (PD-L1) Inhibitor, Olaparib, poly ADP-ribose polymerase (PARP) inhibitor | Sichuan University | Lung Cancer, Extensive-stage Small-cell Lung Cancer | 06/26 | 03/27 | | |
| Lv, Huakun |
NCT04895020: Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years |
|
|
| Recruiting | 3 | 1200 | RoW | 9-valent HPV vaccine | Shanghai Bovax Biotechnology Co., Ltd., Chongqing Bovax Biopharmaceutical Co., Ltd. | HPV Infections, Cervical Cancer, Vulvar Cancer, Vaginal Cancer, CIN1, CIN2, CIN 3, VaIN1, VaIN2, VaIN3, Genital Wart, VIN 1, VIN 2, VIN 3, AIS | 01/23 | 05/26 | | |
NCT05205083: Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV |
|
|
| Recruiting | 1/2 | 480 | RoW | Recombinant novel coronavirus vaccine (CHO cells) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Zhejiang Provincial Center for Disease Control and Prevention | COVID-19 | 03/22 | 07/22 | | |
NCT05205096: Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac |
|
|
| Completed | 1/2 | 480 | RoW | Recombinant novel coronavirus vaccine (CHO cells) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Zhejiang Provincial Center for Disease Control and Prevention | COVID-19 | 06/22 | 07/22 | | |
| He, Hanqing |
NCT05075083: Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD |
|
|
| Recruiting | 4 | 400 | RoW | Inactivated COVID-19 vaccine | China National Biotec Group Company Limited, Zhejiang Provincial Center for Disease Control and Prevention, Beijing Institute of Biological Products Co Ltd. | COVID-19, Chronic Bronchitis, COPD | 06/22 | 06/22 | | |
NCT05075070: Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected |
|
|
| Recruiting | 4 | 400 | RoW | Inactivated COVID-19 vaccine | China National Biotec Group Company Limited, Zhejiang Provincial Center for Disease Control and Prevention, Beijing Institute of Biological Products Co Ltd. | COVID-19, HIV Infections | 06/22 | 06/22 | | |
NCT05105295: Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected |
|
|
| Not yet recruiting | 4 | 400 | RoW | Inactivated COVID-19 vaccine | China National Biotec Group Company Limited, Zhejiang Provincial Center for Disease Control and Prevention, Beijing Institute of Biological Products Co Ltd. | COVID-19, HIV Infections | 06/22 | 06/22 | | |
NCT05104216: Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD |
|
|
| Not yet recruiting | 4 | 400 | RoW | Inactivated COVID-19 vaccine | China National Biotec Group Company Limited, Zhejiang Provincial Center for Disease Control and Prevention, Beijing Institute of Biological Products Co Ltd. | COVID-19, Chronic Bronchitis, COPD | 06/22 | 06/22 | | |
NCT05460429: Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus |
|
|
| Recruiting | 4 | 37920 | RoW | Live attenuated varicella vaccine | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Varicella | 03/23 | 05/23 | | |
NCT06708286: A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) |
|
|
| Recruiting | 2/3 | 1820 | RoW | Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp)), 23-valent Pneumococcal Polysaccharide Vaccine (PPV23), Tdcp, PPV23, Diphtheria-tetanus-acellular pertussis vaccine (DTaP) | CanSino Biologics Inc. | Diphtheria, Tetanus, Pertussis | 05/25 | 05/25 | | |
| Wang, Xiaomeng |
| Completed | 4 | 354 | RoW | PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter Regimen | Huashan Hospital | Multidrug Resistant Tuberculosis | 08/24 | 08/24 | | |
NCT05874700: A Pilot Study of Sivelestat Sodium to Shorten Mechanical Ventilation in Acute Aortic Dissection |
|
|
| Not yet recruiting | N/A | 30 | RoW | Sivelestat sodium was given intravenously, Sivelestat sodium group, Placebo was given intravenously, Placebo control group | Xiaotong Hou | Acute Aortic Dissection | 12/23 | 02/24 | | |
| Zhang, Ronghua |
NCT06204198: Clinicopathological Features and Molecular Typing of Invasive Fibroma of Abdominal Wall |
|
|
| Recruiting | N/A | 150 | RoW | No intervention | Shandong Provincial Hospital | Aggressive Fibromatosis of Abdominal Wall (Disorder) | 02/24 | 09/24 | | |
| Recruiting | N/A | 10000 | RoW | | Westlake University, Zhejiang Provincial Center for Disease Control and Prevention | Metabolic Disease, Cardiovascular Diseases, Healthy Aging | 07/33 | 07/33 | | |
| Su, Danting |
| Recruiting | N/A | 10000 | RoW | | Westlake University, Zhejiang Provincial Center for Disease Control and Prevention | Metabolic Disease, Cardiovascular Diseases, Healthy Aging | 07/33 | 07/33 | | |
| Shenyu, Wang |
NCT06754384: Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). |
|
|
| Not yet recruiting | 1/2 | 552 | RoW | Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell), Medium-dose tetravalent inactivated enterovirus vaccine (Vero cell), High-dose tetravalent inactivated enterovirus vaccine (Vero cell) ), EV71 inactivated enterovirus vaccine (Vero cell) )(for ages 6-71 months）, placebo (for ages 6-12 years) | Sinovac Biotech Co., Ltd | Hand, Foot, and Mouth Disease (HFMD), Herpangina | 01/26 | 08/26 | | |
